XS
NVO

XR Securities’s Novo Nordisk NVO Stock Holding History

XR Securities’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,900
Closed -$414K – 214
2024
Q2 		$414K Sell
2,900
-3,600
-55% -$477K 0.08% 161
2024
Q1 		$835K Buy
+6,500
New +$774K 0.03% 160
2023
Q4 		– Sell
-5,600
Closed -$509K – 424
2023
Q3 		$509K Buy
+5,600
New +$493K 0.04% 249

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

XR Securities's NVO Position: Q1 2023 in Review

XR Securities sold out of Novo Nordisk (NVO) in Q1 2023, closing a stake of 3,834 shares — an estimated $259K sold.

XR Securities first reported a position in NVO in Q4 2022 and held it in 1 quarter. The position peaked at $259K in Q4 2022. 1,146 funds tracked by Wall St. Rank hold NVO as of Q1 2023.

  • XR Securities reported no remaining Novo Nordisk position as of Q1 2023 after selling out during the quarter.
  • XR Securities sold 3,834 Novo Nordisk shares in Q1 2023, an estimated $259K.
  • XR Securities first reported a position in Novo Nordisk in Q4 2022 and held it in 1 quarter.
  • XR Securities's Novo Nordisk position peaked at $259K in Q4 2022.
  • 1,146 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2023.

Based on XR Securities's 13F filing for Q1 2023, filed 2 May 2023.